The goal of this work was to study the efficacy of the positron emission tomography (PET) tracers 2-deoxy-2-[ placental function in preclinical rodent models. These measurements illustrate the potentially irreversible damage generated by chronic exposure to hypoxia, which cannot be corrected by acute exposure to hyperoxia.
T HE PLACENTA MAINTAINS dynamic fetal homeostasis by performing a wide range of physiologic functions, which, after birth, are carried out by multiple organs, such as the kidney, liver, gastrointestinal tract, lungs, and endocrine glands. The primary functions of the placenta are to mediate the transfer of respiratory gases, water, ions, and nutrients; provide an immunologic barrier between fetus and mother; and produce and secrete a vast array of hormones, cytokines, and signaling molecules. Malformations in the structure or function of the placenta, the uterus, or the connection between them can lead to life-threatening sequelae for the mother and progeny. 1, 2 Maternal and fetal blood flow within the placenta and exchange of nutrients and oxygen between the two vascular systems are essential aspects of placenta-fetal units. Insufficiencies in these functions may result in a variety of severe prenatal and postnatal syndromes, including intrauterine growth restriction (IUGR), preeclampsia, and fetal death in utero, as well as a predisposition to systemic cardiovascular and pulmonary vascular dysfunction. [3] [4] [5] [6] Furthermore, increasing epidemiologic evidence has demonstrated that aberrant placental function during fetal development can have long-term negative impacts on human adult health, including increased risk of ischemic heart disease. 7, 8 Acute administration of oxygen is frequently used to reduce fetal hypoxic stress in pregnant women. Characterizing placental function is vital for understanding fetal physiology, growth patterns, and complications during pregnancy. Thus, understanding the factors that affect transport across the placenta can impact both broad areas of basic research and clinical practice. Noninvasive imaging methods can play a key role in assessing the efficiency and integrity of this transport function. A wide variety of preclinical magnetic resonance imaging (MRI) studies of placenta structure and function have been described. [9] [10] [11] [12] [13] ]FDG PET has long been used to measure glucose transport in many disease states and thus is an ideal tracer for our proof-of-principle studies. [19] [20] [21] [22] [23] The overarching goal of our work is to enhance our knowledge of placental-fetal transport of nutrients, in this case glucose, to provide a better understanding of the unique properties of mammalian reproduction. To this end, studies to assess the ability of FDG PET to measure changes in placental function were conducted in normal pregnant animals and pregnant mice exposed to chronic hypoxic conditions. All mice were subject to acute hyperoxia during FDG-PET imaging.
Materials and Methods
All animal experiments were conducted according to the guidelines of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health under a protocol approved by the Washington University Animal Studies Committee. Timed pregnant CD-1 (Crl:CD1(ICR)) mice were obtained from Charles River Laboratories (Wilmington, MA). Hypoxia studies were conducted using a hypoxia chamber (BioSpherix, Lacona, NY), as previously reported. 24 Briefly, mice were fed a standard rodent chow and housed in a 12:12-hour light-dark cycle in room air. The hypoxic atmosphere was maintained at fraction of inspired oxygen (FIO 2 ) = 12% with a ProOx 110 gas oxygen controller (BioSpherix). The hypoxic cohort was exposed to an atmosphere with FIO 2 = 12% beginning on embryonic day 15 (E15) and maintained in a hypoxic environment for 72 hours. Mice were imaged immediately following hypoxic exposure. Cu-ATSM (hypoxic n = 4, normoxic n = 4) was then injected coincidentally with the start of the PET scanning. Dynamic PET images were acquired for 60 minutes. The PET study was followed by the injection of 3.5 mgI/g of body weight Omnipaque (iohexol, 350 mgI/mL, GE Healthcare, Princeton, NJ) equivalent to a dose of 0.028 mmol/kg inorganic iodine through the tail-vein catheter, coincidental with the initiation of 6-minute computed tomography (CT). PET data were reconstructed using standard methods with the maximum a posteriori probability (MAP) algorithm. CT images were overlaid on the PET images, and volumes of interest (VOI) were drawn using CT anatomic guidelines. Additional details can be found in the supplementary information ( Figure S1 and Figure S2 , online version only).
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Statistical Analysis
Data are expressed as mean ± SD unless noted otherwise. Statistical significance was determined with an unpaired, two-tailed Student t-test and 95% confidence level, and p values less than .05 were considered significant. All data were analyzed and plotted using GraphPad Prism version 6.0 (GraphPad Software, La Jolla, CA).
Results and Discussion
To evaluate [ 18 F]FDG as an imaging modality for studying placental function, we investigated the effect of chronic hypoxia on maternal-fetal glucose transport. E15.5 mice were exposed to a hypoxic environment for 72 hours and imaged at E18.5 with [
18 F]FDG as described in the Methods section. To achieve the contrast needed for the anatomically guided structure determination, Omnipaque, an iodinebased CT contrast agent, was used, as described in Methods. Figure 2B . [ 18 F]FDG uptake was significantly higher in the fetuses and placentas of normoxic animals (p = .0001 for both pairs), suggesting a transfer defect in hypoxic animals due to the chronic hypoxic injury, which is not corrected by acute hyperoxia (Table 1) . Interestingly, there was no significant difference in mean tracer uptake between the hypoxic placentas and fetuses (p = .059). Overall, [
18 F]FDG PET demonstrated the robustness required to detect small differences in placentalfetal nutrient transfer.
To evaluate the exposure to chronic tissue hypoxia, hypoxia-challenged animals and normoxic animals were imaged during normal air inhalation using 64 Cu-ATSM, a tracer that is specifically retained in tissues with low O 2 tension. [28] [29] [30] Systemic chronic hypoxia was induced for 72 hours as described in Methods. After injecting 100 mCi of 64 Cu-ATSM, dynamic disintegration data were collected for Cu-ATSM in hypoxic maternal tissue (muscle) was 32,500 ± 6,300 Bq/mL, whereas the normoxic muscle tissue retained an average of 15,800 ± 6,600 Bq/mL. Similar to [ 18 F]FDG uptake, there was no significant difference in 64 Cu-ATSM uptake among maternal tissues, fetuses, or placentas of hypoxic animals ( Figure 3B ). As shown in Figure 3C Cu-ATSM uptake in hypoxic (45,400 ± 17,100 Bq/mL, n = 37) and normoxic (28,600 ± 16,200 Bq/mL, n = 26) placentas ( Figure 3C ) was significantly different (p = .0002). A similar difference was observed when comparing the fetuses of hypoxic (31,700 ± 24,600 Bq/mL, n = 37) and normoxic (15,800 ± 5,600 Bq/mL, n = 26) animals, where p = .002 ( Figure 3D Tchirikov and colleagues, the investigators observed a decrease in fetal organ perfusion, whereas glucose uptake by the fetus was unaffected. 31 Although expensive and logistically complicated, these studies were instrumental in motivating the use of PET for investigating placental-fetal trafficking in preclinical models. Moreover, a broad range of experimental disease states, both acute and chronic, are available in small rodents, enabling a variety of studies of gestational pathologies and their effect on placental-fetal transfer.
In this work, we showed that excellent coregistration of PET and contrast-enhanced CT data could be achieved. However, due to the limitations in spatial resolution of the small animal PET scanner, accumulation of the labeled compound in specific fetal organs could not be determined. Nonetheless, [ 18 F]FDG PET could detect small differences in tracer transfer caused by an experimentally induced pathology that was corroborated by an independent PET tracer. Overall, the use of PET/CT in small animal systems to track placental-fetal transport of a wide range of labeled compounds in normal and/or disease states could lead to a better understanding of prenatal pathologies. 
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Alexander Zheleznyak, Joel R. Garbow, Michal Neeman, and Suzanne E. Lapi Figure S1 . PET/CT maximum intensity projection images of animals injected with 64 Cu-ATSM. F = fetus; P = placenta. Figure S2 . CT image of an E18.5 mouse (A); CT image of an E18.5 mouse indicating region of interest used for quantification (B). F = fetus; P = placenta.
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